Electromagnetic Transduction Therapy (EMTT) Enhances Tenocyte Regenerative Potential: Evidence for Senolytic-like...

Area of Science:

• Musculoskeletal Medicine
• Biomedical Engineering
• Cellular Biology

Background:

• Tendinopathies pose a significant clinical challenge with limited treatment efficacy.
• Electromagnetic transduction therapy (EMTT) is a novel approach, but its cellular mechanisms in tendon healing are unclear.
• Understanding EMTT's effects on tenocytes is crucial for developing effective tendinopathy treatments.

Purpose of the Study:

• To investigate the in vitro effects of EMTT on human tenocyte behavior and function.
• To explore EMTT's impact on tenocyte proliferation, migration, senescence, and matrix production.
• To elucidate the molecular mechanisms underlying EMTT's therapeutic potential for tendinopathies.

Main Methods:

• Primary human tenocytes were cultured from semitendinosus tendon biopsies.
• Cells were exposed to EMTT at varying intensities (40 and 80 mT) and impulse numbers.
• Assays included MTT for viability, Ki67 for proliferation, CDKN2a/INK4a for senescence, scratch test for migration, immunofluorescence for cytoskeleton, and RT-PCR for gene expression.

Main Results:

• EMTT at 80 mT significantly increased tenocyte proliferation (Ki67) and migration.
• A notable downregulation of the senescence marker CDKN2a/INK4a was observed, suggesting senolytic-like activity.
• EMTT upregulated tenogenic markers (Scleraxis, Tenomodulin) and promoted Collagen I and III production, indicating enhanced matrix remodeling.

Conclusions:

• EMTT, particularly at 80 mT, promotes key tenocyte functions essential for tendon repair.
• The therapy exhibits potential senolytic effects, addressing cellular aging in tendinopathies.
• EMTT is a promising regenerative therapeutic strategy for tendinopathies, warranting further in vivo investigation.